PANIC: Psychosocial Patterns and Prognosis in Patients With Heart Failure

Sponsor
Assistance Publique - Hôpitaux de Paris (Other)
Overall Status
Completed
CT.gov ID
NCT00709241
Collaborator
(none)
325
1
60
5.4

Study Details

Study Description

Brief Summary

This prospective observational study is designed to confirm the prognostic and economic impact of depression in ambulatory patients with systolic or diastolic heart failure, to explore the impact of other psychosocial patterns such as type D personality, anxiety disorders, locus of control, perceived social support, anger, hopelessness, and to evaluate potential pathophysiological and behavioral pathways.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Studies suggest that depressive symptoms may be associated with a worse prognosis and higher costs of care in patients with chronic heart failure in some populations, but such data in a French population are missing. On the other hand, little is known of the impact of other psychosocial dysfunction whereas the pathophysiology of this association remains hypothetical.

    Main objective: to confirm the impact of depressive symptoms on cardiovascular death in ambulatory heart failure patients

    Other objectives:
    • to study the impact of depressive symptoms on sudden death, non cardiovascular death, and hospitalization rates;

    • to study the role of other psychosocial patterns or personality traits such as anxiety disorders, locus of control, perceived social support, anger, hopelessness, optimism and type D personality in cardiovascular and total mortality;

    • to study the interaction with patient behaviors (drug compliance, addictions);

    • to explore some pathophysiological pathways (chronic inflammation and chronic loss of myocytes),

    • and to evaluate the impact of psychosocial distress on health care costs. Design: multicenter observational study with a minimum of 2 year follow up Population: 700 ambulatory patients, aged above 18 y.o., with acute heart failure within the last 24 months

    Methodology:
    • psychosocial patterns and personality traits are assessed using validated self-administered questionnaire; use of the Beck Depression Index in this population is validated against the Montgomery & Asberg Depression Rating Scale evaluation

    • cardiac condition is evaluated at pre-defined time period by B-natriuretic peptide levels, echocardiography and 6'-walk test

    End-point criteria:
    • primary : rate of cardiovascular death

    • secondary : rate of total mortality and sudden death, rate of rehospitalization for heart failure and for any cause, total and specific health care costs.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    325 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Prognostic Value of Negative Affectivity in Patients With Heart Failure
    Study Start Date :
    Dec 1, 2007
    Actual Primary Completion Date :
    Dec 1, 2012
    Actual Study Completion Date :
    Dec 1, 2012

    Outcome Measures

    Primary Outcome Measures

    1. Cardiovascular mortality [2 years]

    Secondary Outcome Measures

    1. total mortality, sudden death rate, non cardiovascular mortality, rate of hospitalization, of rehospitalization for heart failure, of hospitalization for cardiovascular and non cardiovascular reasons,total health care costs and nature of theses costs [2 years]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • age above 18,

    • acute heart failure within the last 24 months

    • stable cardiovascular condition for at least 2 weeks

    • non hospitalized, non institutionalized patient,

    • french speaking and reading,

    Exclusion Criteria:
    • Non inclusion criteria :

    • curable cardiomyopathy, cardiomyopathies associated with systemic illnesses (Lupus...), neurodegenerative or pulmonary illnesses, or hypertrophic/restrictive cardiomyopathy

    • unstable cardiovascular condition

    • heart transplant and hemodialysis patient

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hopital Georges pompidou Paris France 75015

    Sponsors and Collaborators

    • Assistance Publique - Hôpitaux de Paris

    Investigators

    • Principal Investigator: François LEDRU, MD PH, Assistance Publique - Hôpitaux de Paris

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Assistance Publique - Hôpitaux de Paris
    ClinicalTrials.gov Identifier:
    NCT00709241
    Other Study ID Numbers:
    • P051044
    First Posted:
    Jul 3, 2008
    Last Update Posted:
    Oct 23, 2014
    Last Verified:
    Oct 1, 2014
    Keywords provided by Assistance Publique - Hôpitaux de Paris
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 23, 2014